Rhythm制药 RYTM 深 沪
等待开盘 05-12 09:30:00 美东时间
87.405
-6.645
-7.07%
华盛通- 最 高97.45
- 今 开93.62
- 成交量 78.16万股
- 最 低 86.76
- 昨 收 94.05
- 总市值 440.47万
- 52周最高 122.20
- 市盈率 静 --
- 换手率 1550.96%
- 52周最低 58.7147
- 委 比 98.78%
- 总股本 5.04万
- 历史最高 122.20
- 量 比 0.86
- 振 幅 11.37%
- 历史最低 1.10
- 每 手 1
- 风险率 15.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rhythm Pharmaceuticals Presents New Data At The Pediatric Endocrine Society Annual Meeting
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the presentation of
05-04 20:06
Rhythm Pharmaceuticals Discloses 18.8% BMI Drop In Rare Obesity Patients
Rhythm Pharma shares rise after Phase 3 data show strong BMI drop. FDA decision on obesity drug due by March 20.
03-02 22:41
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise
Rhythm Pharma rises after early Prader-Willi trial data show reduced hunger and BMI, supporting plans for a Phase 3 study of setmelanotide.
2025-12-12 02:17
Rhythm Pharmaceuticals's Earnings: A Preview
Rhythm Pharmaceuticals (NASDAQ:RYTM) is gearing up to announce its quarterly ea...
2025-11-04 03:01
Insights into Halozyme Therapeutics's Upcoming Earnings
Halozyme Therapeutics (NASDAQ:HALO) will release its quarterly earnings report ...
2025-11-01 02:02
国投证券-生物医药行业新药周观点：创新药5月进院数据更新，多个新纳入医保创新药快速进院中-250713
（转自：研报虎） 本周新药行情回顾： 2025年7月7日-2025年7月13日，新药板块涨幅前5企业：北海康成(114.5%)、前沿生物(41.4%)、君...
2025-07-13 21:23
礼来、诺和诺德之后，下一代减肥药谁主沉浮？
（转自：药剂Talks） 下一代减肥药，正在加速崛起。 4月16日，恒瑞医药启动了siRNA新药HRS-5817用于治疗超重或肥胖的Ⅰ期临床试验。目前，全球范...
2025-05-16 08:36
Assessing Rhythm Pharmaceuticals: Insights From 10 Financial Analysts
10 analysts have shared their evaluations of Rhythm Pharmaceuticals (NASDAQ:RYT...
2025-03-08 02:00
